Appointment of Broker

RNS Number : 9293K
Randall & Quilter Inv Hldgs Ltd
08 January 2021
 

 

 

 

 

Randall & Quilter Investment Holdings Ltd.

 

("R&Q")

 

8 January 2021

 

Appointment of Broker

Randall & Quilter Investment Holdings Ltd. ("Randall & Quilter") today announces the appointment of Barclays Bank PLC ("Barclays") as its joint corporate broker with immediate effect. Barclays will work alongside Randall & Quilter's existing corporate broker and nominated adviser, Numis Securities Limited.

 

 

-Ends-

 

 

Randall & Quilter Investment Holdings Ltd.

 

Ken Randall

William Spiegel

 

Tel: +44 (0)7831 145440

Tel: +001 917 826 5877

Numis Securities Limited (Nominated Adviser and Joint Corporate Broker)

Stuart Skinner / Huw Jeremy

Tel: 020 7260 1000

Charles Farquhar

Tel: 020 7260 1000

 

Barclays Bank PLC (Joint Corporate Broker)

Mark Astaire                                                                           Tel: 020 7632 2322

Milan Solanki                                                                                 Tel: 020 7632 2322

 

FTI Consulting

Edward Berry

Tom Blackwell

 

 

Tel: 020 3727 1046

 

 

 

 

 

Notes to Editors:

 

About R&Q 

R&Q is a non-life global specialty insurance company operating two core, highly complementary, businesses: Program Management and Legacy Insurance. Both these businesses are leaders in markets with high barriers to entry and significant secular growth opportunities.  Legacy Insurance generates profits and capital extractions from expert management of legacy non-life insurance portfolios. Program Management generates commission income from its licensed (and rated) carriers in the US, EU and the UK, writing niche and profitable program business, largely on behalf of highly rated reinsurers.

Legal Entity Identifier (LEI): 2138006K1U38QCGLFC94

 

Website: www.rqih.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPUBRARASUARAR
UK 100

Latest directors dealings